Diabetes News and Research

Latest Diabetes News and Research

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Patients with inflammatory bowel disease (IBD) suffer from chronic inflammation of the gut leading to gastrointestinal motility alterations with symptoms such as abdominal pain, cramps and diarrhea that profoundly affect their quality of life. The lack of exposure to worm infections, as a result of improved living standards and medical conditions, might have contributed to the increased incidence of IBD in the Western world.

5 Mar 2010

Proper treatment can help control psoriasis in most cases

For the approximately 7.5 million Americans affected by psoriasis, the thick, red, scaly, itchy plaques it causes only scratch the surface when it comes to the overall implications of this disease. Now, ongoing research linking psoriasis to other serious medical conditions and the incredible toll it can take on a person's overall quality of life are shifting the way psoriasis is viewed - from a common skin disease to a complex systemic condition.

5 Mar 2010

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

The Heart and Stroke Foundation (HSF) is concerned with the lack of any substantive funding in support of heart health initiatives as outlined in today's 2010 Federal Budget.

5 Mar 2010

Neurocrine Biosciences to sell common stock shares

Neurocrine Biosciences, Inc. today announced that it is offering to sell shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. is the sole book-running manager for this offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

5 Mar 2010

KAPIDEX to be marketed as DEXILANT in the U.S.

Takeda Pharmaceuticals North America, Inc. announced today that KAPIDEX™ (dexlansoprazole) will be marketed in the United States under the new product trade name DEXILANT™ (dexlansoprazole). The product is indicated for heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD), the healing of erosive esophagitis (EE) and the maintenance of healed EE.

5 Mar 2010

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Data evaluating the efficacy and safety of STELARA™ (ustekinumab) and REMICADE® (infliximab) in patients with plaque psoriasis who had an inadequate response to Enbrel® (etanercept) will be presented at the 68th Annual Meeting of the American Academy of Dermatology (AAD) in Miami, Fla., from March 5-9, 2010.

5 Mar 2010

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte’s lead regenerative medicine product using Xcellerex’s XDR single use bioreactor system in its FlexFactory®. Humacyte’s product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

Toxicologists, environmental health scientists to discuss on safeguarding public health at SOT meeting

The government's leading toxicologists and environmental health scientists will share their latest scientific accomplishments, offer continuing education courses, discuss funding and training opportunities, receive input on future research priorities, and more, at the Society of Toxicology annual meeting.

5 Mar 2010

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

For many women, unexplained hair loss can take a significant psychological toll on their overall quality of life. From altering their hairstyle to hide a thinning part to scaling back their hair care regimen in an effort to halt further hair loss, women try countless ways to cover up this problem - and the results are often lukewarm at best.

4 Mar 2010

Valley Presbyterian Hospital announces opening of premier Amputation Prevention Center

Valley Presbyterian Hospital is proud to announce the planned red-carpet grand-opening on March 17th of its premier Amputation Prevention Center (APC), an integrated limb-preservation center that is one of the nation’s only facilities of its kind.

4 Mar 2010

25th Alzheimer's Disease International conference: Focus on new treatment developments

"What's new" in Alzheimer's disease medical treatments and diagnosis is the focus of the first day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 11, 2010 at the Grand Hotel Palace, Thessaloniki, Greece.

4 Mar 2010

Soccer can be effective training method to reduce bone weakening that comes with increasing age

The observed improvements in bone mineral density, strength and postural balance due to recreational soccer are of particularly interest for a large group of women but also for elderly men, says project leader Associate Professor Peter Krustrup, University of Copenhagen, and continues "It is well known that the risk of falls and fractures increases with age as a result of weaker bones, poorer balance and attenuated ability to trigger rapid muscle force, but the present results suggest that soccer - and possibly other ball games - is an effective training method to reduce bone weakening that comes with increasing age".

4 Mar 2010

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.

4 Mar 2010

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.

4 Mar 2010

Study analyzes Rx purchasing habits of dLife members prior to and after engaging with dLife

A new study analyzing patient-level prescription data clearly demonstrates that dLife consumers take immediate and deeper action in treating their diabetes and co-morbid conditions after becoming engaged with dLife. The study also confirms that dLife users test their blood sugar and take medications at a higher rate than non-dLife users.

4 Mar 2010

Pycnogenol counteracts kidney damage due to hypertension

An estimated one in ten adults suffers from kidney disease, according to the National Institute of Diabetes and Digestive and Kidney Diseases. A leading cause of kidney disease is hypertension, which effects one out of every four U.S. adults. Chronically high blood pressure damages capillaries of the kidneys which in turn affects the organ's ability to filter waste and remove excess fluids from the body.

4 Mar 2010

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Mar 2010

St. Jude Medical publishes clinical results of HOMEOSTASIS trial

St. Jude Medical, Inc. today announced publication of clinical results in the Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOMEOSTASIS) trial.

4 Mar 2010

Corning commercializes new Synthemax synthetic surface for supporting growth and differentiation of stem cells

Corning Incorporated today introduced the Corning® Synthemax™ surface, a novel synthetic surface that supports the growth and differentiation of stem cells. The surface is being commercialized as a result of Corning’s ongoing collaboration with Geron Corporation. This development enables researchers to take the next step toward scalable and cost-effective manufacturing of stem cells for potential therapies in the treatment of degenerative diseases.

4 Mar 2010

Diabetes News and Research

Latest Diabetes News and Research

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Proper treatment can help control psoriasis in most cases

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

Neurocrine Biosciences to sell common stock shares

KAPIDEX to be marketed as DEXILANT in the U.S.

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Proper diagnosis, treatment and good skin care help control acne and rosacea

Toxicologists, environmental health scientists to discuss on safeguarding public health at SOT meeting

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

Valley Presbyterian Hospital announces opening of premier Amputation Prevention Center

25th Alzheimer's Disease International conference: Focus on new treatment developments

Soccer can be effective training method to reduce bone weakening that comes with increasing age

Childhood absence epilepsy: Comparative clinical trial of widely used anti-seizure drugs

AARDA report examining current state of AD released at the National Autoimmune Diseases Summit

Study analyzes Rx purchasing habits of dLife members prior to and after engaging with dLife

Pycnogenol counteracts kidney damage due to hypertension

HbA1c levels help predict future diabetes more accurately than fasting glucose measurements

St. Jude Medical publishes clinical results of HOMEOSTASIS trial

Corning commercializes new Synthemax synthetic surface for supporting growth and differentiation of stem cells

Mastering RNA extraction for plant and fungal research – eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Diabetes News and Research

Latest Diabetes News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in